Naive and breakthrough infections with BA.2, BA.5 and BF.7 variants provide poor cross protection against XBB related variants.

Yang, Yang; Gong, Xiaohua; Tang, Yimin; Liu, Jiexiang; Zeng, Lijiao; Kuang, Jiahua; Wang, Fuxiang; Lu, Hongzhou; Liu, Yingxia

Yang, Yang; Gong, Xiaohua; Tang, Yimin; Liu, Jiexiang; Zeng, Lijiao; Kuang, Jiahua; Wang, Fuxiang; Lu, Hongzhou; Liu, Yingxia.

Yang Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China. Electronic address:
Gong X; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Tang Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Liu J; Guangzhou University of Traditional Chinese Medicine, China.
Zeng L; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Kuang J; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.
Wang F; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China. Electronic address:
Lu H; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China. Electronic address:
Liu Y; Shenzhen Key Laboratory of Pathogen and Immunity, National Clinical Research Center for Infectious Disease, State Key Discipline of Infectious Disease, Shenzhen Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China. Electronic address:

J Infect ; 87(2): 156-159, 2023 08.

Статья | MEDLINE | ID: covidwho-20245746

Тема - темы

Полный текст

Печатать

XML

PubMed Links

Search on Google

Полный текст: Имеется в наличии Коллекция: Международные базы данных база данных: MEDLINE Основная тема: Cross Protection / Breakthrough Infections Тип исследования: Рандомизированные контролируемые испытания Темы: Вакцина / Варианты Пределы темы: Люди Журнал: J Infect Год: 2023 Тип: Статья

Документы, близкие по теме

MEDLINE

LILACS

LIS

Полный текст

Печатать

XML

PubMed Links

Search on Google